1.Observation on therapeutic effect of Laci Staw combined with nimodipine on vascular dementia after cerebral infarction
Tao LI ; Xinqian YANG ; Jinping LI ; Qihuang ZHAO
Chinese Journal of Biochemical Pharmaceutics 2017;37(6):288-289
Objective To observe the effect of nimodipine combined with nimodipine on cerebral vascular dementia after cerebral infarction.MethodsFrom February 2009 to March 2012, 32 patients with vascular dementia after cerebral infarction were selected in Beijing Chaoyang hospital.Among them, there were 19 males and 13 females, aged 63~84 years old.The patients were randomly divided into two groups, each group of 16 patients.The patients in the treatment group were treated with oral nimodipine combined with Piracetam Tablets.ResultsThe effective rate of the treatment group was 93.8%, the adverse reaction rate was 6.3%, while the control group was effective, the adverse reaction rate was 18.8%, the difference between the two groups was significant (P<0.05).ConclusionIn the treatment of patients with vascular dementia after cerebral infarction, the use of nimodipine combined with nimodipine has significant curative effect and less adverse reaction rate, which is worthy of clinical application.
2.The clinical efficacy of treatment of subarachnoid hemorrhage with Danshen solution combine nimodipine
Xinqian YANG ; Tao LI ; Jinping LI ; Qihuang ZHAO
Chinese Journal of Biochemical Pharmaceutics 2017;37(6):126-128
Objective To observe the clinical efficacy of treatment of subarachnoid hemorrhage with Danshen solution combine nimodipine.Methods80 cases diagnosis with subarachnoid hemorrhage from January 2014 to February 2015, were randomly divided into observation group and control group 40cases, observation group were plus conventional therapy Danshen solution treatment, the control group were given nimodipine only conventional treatment, recorded and analyzed before and after treatment S-100B protein in cerebrospinal fluid situation, status and treatment of disease incidence of complications in patients with two groups of patients.ResultsTreatment 5d, 7d, 14d after S-100B protein were observed in patients (0.788±0.014)μg/L,(0.625±0.15)μg/L,(0.501±0.13)μg/L, were better than the control group (0.957±0.16)μg/L,(0.823±0.17)μg/L,(0.711±0.12)μg/L, and the differences were statistically significant (P<0.05).Treatment observation group total effective rate of 90.0%, higher than 67.5%, and the difference was significant (P<0.05).The treatment group rebleeding, cerebral ischemia, hydrocephalus and other complications with the control group fairly, the difference was not significant.ConclusionIt is effective for the treatment of subarachnoid hemorrhage withdanshen solution combine nimodipine, can significantly improve the cure rate in patients with subarachnoid hemorrhage, reducing mortality.It is worthy of further research and applications.
3.Analysis of the quality of life in patients with severe acute respiratory syndrome for 10 years
Jingna HUA ; Xin SUN ; Qi WU ; Li LI ; Zhiheng XING ; Xinqian ZHAO
Tianjin Medical Journal 2016;44(10):1247-1250,1251
Objective To analyse the quality of life in patients with severe acute respiratory syndrome (SARS) for 10 years. Methods Twenty-five SARS patients were collected as SARS group and 25 healthy persons were used as control group. There were no significant differences in general clinical data between two groups. The quality of life of the respondents was evaluated by the MOS item short form health survey (SF-36) including physiological function, physical pain, general health condition, energy, social function, emotional function and mental health. The pulmonary function indicators including forced vital capacity (FVC), one second forced expiratory volume (FEV1), one second rate (FEV1/FVC), total lung capacity (TLC), residual volume (RV), corrected breath diffusing capacity (TLCOc SB) and corrected dispersion rate TLCOc/VA were also compared between two groups. The correlation between each dimension score of pulmonary function indexes and quality of life were analyzed in SARS group. Data of hip and femoral head necrosis were detected by MRI scan in SARS group of patients. Results Total quality of life score was poor in 23 cases (92.0%), and moderate quality of life score in 2 cases (8.0%). The quality of life score was lower in SARS group than that of control group (P<0.01). Data of TLCOc SB was lower in SARS group than that of control group. The score of physiological function was positively correlated with FEV1 and FEV1/FVC. The score of physical pain was positively correlated with FEV1/FVC (P<0.05). There were no significant differences between quality of life score and pulmonary function indicators. There were 11 cases (44%) of avascular necrosis of femoral head, and 14 cases (56%) of non-avascular necrosis of femoral head in SARS group. The score of physiological function was lower in femoral head necrosis group than that of non necrosis group (P<0.05). ConclusionThe lower quality of life in patients with SARS is not only related with psychological factors but also related with physical factors. The damage of pulmonary function and (or) necrosis of femoral head affect the quality of life in patients with SARS, especially the physiological function.
4.Microsurgical treatment of ruptured intracranial aneurysms in the early and intermediate stage
Jinping LI ; Qihuang ZHAO ; Yongquan SUN ; Tong LI ; Yinglun SONG ; Xinqian YANG ; Yu WANG ; Ke TAN ; Tao LI
Clinical Medicine of China 2009;25(12):1301-1303
Objective To explore the microsurgical method in treating ruptured aneurysms treatment and evaluating the treatment of the complication during or after the operation.Methods 36 cases of patients with intracranial aneurysm were analyzed retrospectively.All of the patients were subarachnoid hemorrhage (SAH) by CT scan on admission.The intracranial aneurysms were confirmed in 35 cases by DSA examination and A2 aneurysm was confirmed by explorative operation in 1 case.The microsurgical treatment was performed in 36 cases at the early or intermediate stage,22 cases were treated in the early stage,the other 14 cases were treated in the intermediate stage (early stage means within 3 days post SAH;intermediate stage means from 4 days to 10 days post SAH).Results After the operation,21 cases were GOS grade Ⅰ,4 cases were COS grade Ⅱ,4 cases were COS grade Ⅲ,4 cases were GOS grade Ⅳ.Of all the patients,CT scan was done after the operation,finding no intracranial bemorrhage,and cerebral infarction was disclosed in 5 cases.3 cases were dead,one suffered occipital lobe infaret after the PCoA aneurysm clipped,brain hernia occurred at last,one's Hunt Hess grade was Ⅴ,ACoA aneurysm was disclosed by DSA examination,severe brain edema occurred after the operation,the other suffered tonsillar hernia one week after the aneurysm clipping,which ruptured after endovascular treatment of ACoA aneurysm 2 years later.DSA examinations were done in 26 cases after operation,declaring 1 ACoA aneurysm was unclipped,1 PCoA aneurysm was incompletely clipped,and 1 PCoA was sacrificed.Conclusions It is a valuable method to clip the ruptured intracranial aneurysms in early and intermediate stage.The cerebral ischemia is the severe complication after clipping.Especially for the PCoA aneurysms,it is very important to protect the PCoA.Further research should be done for the treatment in the case with mother artery arteriosclerosis and thrombosis within the aneurysms.
5.Role of Oxidative Stress in Ulcerative Colitis and Traditional Chinese Medicine Prevention and Treatment: A Review
Bo CHEN ; Xitong SUN ; Xinqian DONG ; Wei WANG ; Hongquan SONG ; Jiting ZHAO ; Ya ZHENG ; Honghao ZHANG ; Qingxin LUAN ; Kangning ZHAO ; Hualiang DENG ; Zhen SUN
Chinese Journal of Experimental Traditional Medical Formulae 2023;29(16):264-273
Ulcerative colitis (UC) is a commonly seen digestive system disease with unclear pathogenesis. The condition is complex and variable, often chronic, and has a long treatment period with no specific cure. Currently, the treatment of UC often involves the use of corticosteroids, aminosalicylates, and biologics in western medicine, which provide fast-acting and definite efficacy in the short term. However, with prolonged medication, some patients may develop drug resistance and worsening of the disease, leading to the occurrence of colon cancer. Research has found that oxidative stress is one of the important pathogenic factors in UC and influences its onset and development. Oxidative stress is a state of imbalance between oxidative products and the antioxidant system in the body, characterized by overexpression of oxidative products such as malondialdehyde (MDA), reactive oxygen species (ROS), nitric oxide (NO), or deficiency of antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT), and glutathione (GSH). It is worth noting that traditional Chinese medicine (TCM), as a unique characteristic medicine of China, has achieved significant efficacy in the treatment of UC. Studies have shown that TCM effectively inhibits the occurrence of UC by suppressing the accumulation of metabolites and antagonizes the development of UC by enhancing the antioxidant system. Therefore, using TCM to regulate the oxidative balance as a diagnostic and therapeutic approach may be a new method and direction for the treatment of UC in the future. Based on the above research, this article summarized the mechanisms of key pathogenic proteins in oxidative stress and the occurrence and development of UC, and compiled the effective ingredients of Chinese medicine, single drugs, prescriptions, and acupuncture and moxibustion in regulating upstream and downstream target proteins of oxidative stress. These interventions can reduce pathological damage to the intestinal mucosa, lower the colon injury index, enrich the intestinal microbiota, increase colon length, and improve clinical symptoms of UC. The article is expected to expand the application of TCM in the treatment of UC and provide a reliable scientific theoretical basis.
6.Characteristics of staphylococcal cassette chromosome mec and lugdunin operon genes in the complete genome of Staphylococcus lugdunensis.
Shining FU ; Yusheng CHEN ; Ke HU ; Tian QIN ; Yukun HE ; Lili ZHAO ; Xinqian MA ; Li CHEN ; Wenyi YU ; Yan YU ; Yu XIE ; Yifan WANG ; Donghong YANG ; Yu XU ; Zhancheng GAO
Chinese Medical Journal 2023;136(11):1367-1369